(NASDAQ: MEDP) Medpace Holdings's forecast annual revenue growth rate of 3.52% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.4%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.07%.
Medpace Holdings's revenue in 2025 is $2,156,580,000.On average, 5 Wall Street analysts forecast MEDP's revenue for 2025 to be $62,763,712,630, with the lowest MEDP revenue forecast at $62,357,794,886, and the highest MEDP revenue forecast at $62,952,746,193. On average, 5 Wall Street analysts forecast MEDP's revenue for 2026 to be $63,867,476,641, with the lowest MEDP revenue forecast at $62,946,997,871, and the highest MEDP revenue forecast at $65,157,227,603.
In 2027, MEDP is forecast to generate $69,710,990,650 in revenue, with the lowest revenue forecast at $66,697,777,845 and the highest revenue forecast at $72,796,747,275.